Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK, S7N 5E3, Canada.
Neuroscience Major, Rhodes College, Memphis, TN, USA.
Arch Virol. 2022 Oct;167(10):1925-1930. doi: 10.1007/s00705-022-05513-8. Epub 2022 Jun 28.
Coronaviruses can have a devastating impact on the health of humans and animals. Porcine epidemic diarrhea virus (PEDV) causes extremely high fatality rates in neonatal piglets, whereas severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current COVID-19 pandemic in humans. As a critical component of the host antiviral innate immune response, type I interferon production and signaling play a very important role, especially in the initial phase of the antiviral responses. Coronaviruses have evolved multiple ways to counteract type I interferon responses. Although the primary functions of the nucleocapsid protein are to facilitate viral RNA replication and package viral genomic RNA into virions, recent studies have shown that the nucleocapsid protein is also involved in virus-host interactions. The aim of this review is to summarize our current understanding of how the nucleocapsid proteins of PEDV and SARS-CoV-2 modulate type I interferon responses. This knowledge will be useful for developing strategies to combat coronavirus infections.
冠状病毒会对人类和动物的健康造成严重影响。猪流行性腹泻病毒(PEDV)可导致新生仔猪极高的死亡率,而严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)则是导致当前人类 COVID-19 大流行的罪魁祸首。作为宿主抗病毒先天免疫反应的关键组成部分,I 型干扰素的产生和信号转导起着非常重要的作用,特别是在抗病毒反应的初始阶段。冠状病毒已经进化出多种对抗 I 型干扰素反应的方法。尽管核衣壳蛋白的主要功能是促进病毒 RNA 复制并将病毒基因组 RNA 包装到病毒粒子中,但最近的研究表明,核衣壳蛋白还参与了病毒-宿主相互作用。本综述的目的是总结我们目前对 PEDV 和 SARS-CoV-2 的核衣壳蛋白如何调节 I 型干扰素反应的理解。这些知识将有助于开发对抗冠状病毒感染的策略。